Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CEST
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: [email protected]

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
05/26 PHOTOCURE : Jeremy Bahr appointed Chief Business Officer
05/26 PHOTOCURE : Appoints Three New Members to its Board of Directors
05/23 PHOTOCURE ASA : Results for the first quarter of 2017
05/18PHOTOCURE ASA : quaterly earnings release
05/16 PHOTOCURE ASA : Presentation of the first quarter 2017 results and the results f..
05/15 PHOTOCURE : Positive data from Phase 3 US Blue Light Cystoscopy with Cysview® st..
05/12 PHOTOCURE ASA : Phase 3 study investigating Blue Light Flexible Cystoscopy with ..
05/08PHOTOCURE ASA : quaterly earnings release
05/05 PHOTOCURE : Jeremy Bahr appointed Chief Business Officer
04/28 PHOTOCURE : Appoints Three New Members to its Board of Directors
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
Advertisement
Financials ( NOK)
Sales 2017 150 M
EBIT 2017 -37,1 M
Net income 2017 -29,6 M
Finance 2017 111 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 134,47
EV / Sales 2017 3,79x
EV / Sales 2018 2,61x
Capitalization 681 M
More Financials
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 36,0  NOK
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-22.62%81
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.88%236 581
NOVARTIS AG6.75%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results